[1] |
PAROLA M, PINZANI M. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues[J]. Mol Aspects Med, 2019, 65: 37-55. DOI: 10.1016/j.mam.2018.09.002.
|
[2] |
LIU FW. The curative effect of Taohong Siwu Decoction in the treatment of decompensated cirrhosis and its effect on coagulation function[J]. Mod J Integr Tradit Chin West Med, 2016, 25(15): 1662-1664. DOI: 10.3969/j.issn.1008-8849.2016.15.023.
刘发文. 桃红四物汤加减治疗失代偿期肝硬化的疗效及对凝血功能的影响[J]. 现代中西医结合杂志, 2016, 25(15): 1662-1664. DOI: 10.3969/j.issn.1008-8849.2016.15.023.
|
[3] |
WANG WQ, WANG BX, SHAO WW. The effect of Angelica on the content of liver collagen protein of hepatic fibrosis rats induced by CCl4[J]. Heilongjiang Med Pharm, 2003, 26(3): 25. DOI: 10.3969/j.issn.1008-0104.2003.03.011.
王伟群, 王柏欣, 邵文武. 当归对CCl4致大鼠肝纤维化胶原蛋白含量的影响[J]. 黑龙江医药科学, 2003, 26(3): 25. DOI: 10.3969/j.issn.1008-0104.2003.03.011.
|
[4] |
WANG YQ. Anti hepatic fibrosis effect of peach kernel extract and its molecular mechanism[J]. J Med Theor & Pract, 2014, 27(15): 2015-2016. DOI:10.3969/j.issn.1008- 0104.2003.03.011.
王玉清. 桃仁提取物抗肝纤维化作用及其分子机制研究[J]. 医学理论与实践, 2014, 27(15): 2015-2016. DOI:10.3969/j.issn.1008- 0104.2003.03.011.
|
[5] |
MCQUITTY CE, WILLIAMS R, CHOKSHI S, et al. Immunomodulatory role of the extracellular matrix within the liver disease microenvironment[J]. Front Immunol, 2020, 11: 574276. DOI: 10.3389/fimmu.2020.574276.
|
[6] |
WANG F, CHANG HM, YI Y, et al. TGF-β1 promotes hyaluronan synthesis by upregulating hyaluronan synthase 2 expression in human granulosa-lutein cells[J]. Cell Signal, 2019, 63: 109392. DOI: 10.1016/j.cellsig.2019.109392.
|
[7] |
LIU C, YUAN X, TAO L, et al. Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways[J]. BMC Complement Altern Med, 2015, 15: 201. DOI: 10.1186/s12906-015-0733-1.
|
[8] |
SHI K, LIU Y, WANG X, et al. Adjuvant Fuzheng Huayu Capsule reduces the incidence of hepatocellular carcinoma in patients with hepatitis B-caused cirrhosis[J]. Evid Based Complement Alternat Med, 2020, 2020: 8826091. DOI: 10.1155/2020/8826091.
|
[9] |
ZHANG W, YANG GY, SHEN DX, et al. Mechanism of action of Xiayuxue decoction in inhibiting liver fibrosis by regulating glial cell line-derived neurotro phic factor[J]. J Clin Hepatol, 2021, 37(3): 575-581. DOI: 10.3969/j.issn.1001-5256.2021.03.015.
张玮, 杨广越, 沈东晓, 等. 下瘀血汤抑制胶质细胞源性神经营养因子抗肝纤维化的作用机制[J]. 临床肝胆病杂志, 2021, 37 (3): 575-581. DOI: 10.3969/j.issn.1001-5256.2021.03.015.
|
[10] |
LI ZY, TIAN YZ. Treatment of liver fibrosis by the Tibetan medicine Lang Qing A Ta according to stasis and heat[J]. J Changchun Univ Chin Med, 2019, 35(6): 1223-1225. DOI: 10.13463/j.cnki.cczyy.2019.06.061.
李忠意, 田耀洲. 藏药郎庆阿塔从瘀热论治肝纤维化[J]. 长春中医药大学学报, 2019, 35(6): 1223-1225. DOI: 10.13463/j.cnki.cczyy.2019.06.061.
|
[11] |
CHEN FY, TU CT. The role and molecular mechanism of Notch signaling transduction pathway on liver fibrogenesis[J/CD]. Chin J Liver Dis(Electronic Edition), 2020, 12(4): 23-28. DOI: 10.3969/j.issn.1674-7380.2020.04.004.
陈方园, 涂传涛. Notch信号转导通路在肝纤维化形成中的作用与分子机制[J/CD]. 中国肝脏病杂志(电子版), 2020, 12(4): 23-28. DOI: 10.3969/j.issn.1674-7380.2020.04.004.
|
[12] |
KISSELEVA T, BRENNER D. Molecular and cellular mechanisms of liver fibrosis and its regression[J]. Nat Rev Gastroenterol Hepatol, 2021, 18(3): 151-166. DOI: 10.1038/s41575-020-00372-7.
|
[13] |
YUAN H, ZHAO C, BAO X, et al. Anti-liver fibrosis effect of total flavonoids from Scabiosa comosa Fisch. ex Roem. et Schult. on liver fibrosis in rat models and its proteomics analysis[J]. Ann Palliat Med, 2020, 9(2): 272-285. DOI: 10.21037/apm.2020.02.29.
|
[14] |
PASSI A, VIGETTI D, BURASCHI S, et al. Dissecting the role of hyaluronan synthases in the tumor microenvironment[J]. FEBS J, 2019, 286(15): 2937-2949. DOI: 10.1111/febs.14847.
|
[15] |
YANG YM, NOUREDDIN M, LIU C, et al. Hyaluronan synthase 2-mediated hyaluronan production mediates Notch1 activation and liver fibrosis[J]. Sci Transl Med, 2019, 11(496): eaatg284. DOI: 10.1126/scitranslmed.aat9284.
|